Key statistics
On Friday, Cassava Sciences Inc (SAVA:NAQ) closed at 26.95, -36.14% below its 52-week high of 42.20, set on Aug 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 25.00 |
---|---|
High | 27.98 |
Low | 24.75 |
Bid | 26.51 |
Offer | 26.90 |
Previous close | 25.34 |
Average volume | 1.43m |
---|---|
Shares outstanding | 47.98m |
Free float | 41.56m |
P/E (TTM) | -- |
Market cap | 1.29bn USD |
EPS (TTM) | -0.4054 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
- Cassava Sciences Reports Q3 2024 Financial and Operating Results
- Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024
- Cassava Sciences Resolves SEC Investigation
- Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
- Cassava Sciences Names Rick Barry as Chief Executive Officer
- Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
- Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates
- Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson
- Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8:30 am ET
- Cassava Sciences Announces Expansion of Open-Label Extension Trials
More ▼